Telaglenastat With Radiation Therapy and Temozolomide in Treating Patients With IDH-Mutated Diffuse Astrocytoma or Anaplastic Astrocytoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Debiopharm International SA
Children's Oncology Group
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
Northwestern University
European Organisation for Research and Treatment of Cancer - EORTC
Mayo Clinic
BioMimetix JV, LLC
Oslo University Hospital
Radiation Therapy Oncology Group
Radiation Therapy Oncology Group
Candel Therapeutics, Inc.
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
Candel Therapeutics, Inc.
City of Hope Medical Center
Children's Oncology Group
St. Jude Children's Research Hospital
Wake Forest University Health Sciences
Baylor College of Medicine
Sun Yat-sen University
NRG Oncology
Northwestern University
Radiation Therapy Oncology Group
Children's Oncology Group
Dr. Negrin University Hospital
Societe Internationale d'Oncologie Pediatrique
Sheba Medical Center
Washington University School of Medicine
European Organisation for Research and Treatment of Cancer - EORTC
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)
Exelixis
Sun Yat-sen University
National Cancer Institute (NCI)
University of California, San Francisco
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)